{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T01:57:11Z","timestamp":1777773431284,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/00776\/2020-4B"],"award-info":[{"award-number":["UIDP\/00776\/2020-4B"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/00776\/2020-4"],"award-info":[{"award-number":["UIDP\/00776\/2020-4"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["DL57\/2016\/CP1360\/CT006"],"award-info":[{"award-number":["DL57\/2016\/CP1360\/CT006"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2020.08193"],"award-info":[{"award-number":["2020.08193"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijbiomac.2024.137993","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T10:54:22Z","timestamp":1732618462000},"page":"137993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Extracellular vesicles derived-microRNAs predicting enzalutamide-resistance in 3D spheroid prostate Cancer model"],"prefix":"10.1016","volume":"284","author":[{"given":"In\u00eas","family":"Tavares","sequence":"first","affiliation":[]},{"given":"Mariana","family":"Morais","sequence":"additional","affiliation":[]},{"given":"Francisca","family":"Dias","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Gabriela","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"S\u00edlvia Joana","family":"Bidarra","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[]},{"given":"Ana Lu\u00edsa","family":"Teixeira","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.137993_bb0005","doi-asserted-by":"crossref","unstructured":"Wang, L., et al., Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019. Front. Public Health, 2022. 10.","DOI":"10.3389\/fpubh.2022.811044"},{"key":"10.1016\/j.ijbiomac.2024.137993_bb0010","author":"Society"},{"issue":"5928","key":"10.1016\/j.ijbiomac.2024.137993_bb0015","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.1168175","article-title":"Development of a second-generation antiandrogen for treatment of advanced prostate cancer","volume":"324","author":"Tran","year":"2009","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.137993_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25102448","article-title":"Second-generation androgen receptor antagonists as hormonal therapeutics for three forms of prostate Cancer","volume":"25","author":"Rajaram","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2024.137993_bb0025","first-page":"875","article-title":"Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer","volume":"7","author":"Semenas","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"issue":"801","key":"10.1016\/j.ijbiomac.2024.137993_bb0030","article-title":"Second-generation antiandrogens: from discovery to standard of Care in Castration Resistant Prostate Cancer. Frontiers","volume":"9","author":"Rice","year":"2019","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.137993_bb0035","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/PPO.0b013e318282635a","article-title":"Androgen receptor antagonists in castration-resistant prostate cancer","volume":"19","author":"Rathkopf","year":"2013","journal-title":"Cancer J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.137993_bb0040","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/oncolo\/oyab045","article-title":"Rational second-generation antiandrogen use in prostate Cancer","volume":"27","author":"Orme","year":"2022","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.137993_bb0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/medsci10020025","article-title":"Mechanisms of resistance to second-generation antiandrogen therapy for prostate Cancer: actual knowledge and perspectives","volume":"10","author":"Pinto","year":"2022","journal-title":"Medical Sciences"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.137993_bb0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41416-021-01610-8","article-title":"Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research","volume":"126","author":"Ramirez-Garrastacho","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.137993_bb0055","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.3390\/cells9122653","article-title":"Androgen receptor signaling pathway in prostate Cancer: from genetics to clinical applications","volume":"9","author":"Aurilio","year":"2020","journal-title":"Cells"},{"issue":"39","key":"10.1016\/j.ijbiomac.2024.137993_bb0060","doi-asserted-by":"crossref","first-page":"64447","DOI":"10.18632\/oncotarget.10901","article-title":"Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer","volume":"7","author":"Wadosky","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2024.137993_bb0065","first-page":"9","article-title":"Androgen receptor signaling in the development of castration-resistant prostate Cancer. Frontiers","author":"Feng","year":"2019","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.137993_bb0070","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1586\/eem.11.33","article-title":"Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer","volume":"6","author":"Knudsen","year":"2011","journal-title":"Expert. Rev. Endocrinol. Metab."},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.137993_bb0075","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/pros.20460","article-title":"Epidermal growth factor receptor (ErbB1) expression in prostate cancer progression: correlation with androgen independence","volume":"66","author":"Shah","year":"2006","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.137993_bb0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.137993_bb0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-019-0965-7","article-title":"Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance","volume":"18","author":"Maacha","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.137993_bb0090","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41392-021-00817-8","article-title":"Circulating tumor cells: biology and clinical significance","volume":"6","author":"Lin","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.137993_bb0095","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/acs.chemrev.7b00534","article-title":"New Technologies for Analysis of extracellular vesicles","volume":"118","author":"Shao","year":"2018","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.137993_bb0100","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/cells8070727","article-title":"Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis","volume":"8","author":"Doyle","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.137993_bb0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: biology and emerging therapeutic opportunities","volume":"12","author":"S","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.137993_bb0110","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41571-018-0036-9","article-title":"Extracellular vesicles in cancer - implications for future improvements in cancer care","volume":"15","author":"Xu","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2024.137993_bb0115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/1471-2164-14-319","article-title":"Characterization of human plasma-derived exosomal RNAs by deep sequencing","volume":"14","author":"Huang","year":"2013","journal-title":"BMC Genomics"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.137993_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1672-0229(08)60044-3","article-title":"A brief review on the mechanisms of miRNA regulation","volume":"7","author":"Cai","year":"2009","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2024.137993_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6524-3_1","article-title":"MiRNA biogenesis and regulation of diseases: an overview","volume":"1509","author":"Vishnoi","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2024.137993_bb0130","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1080\/00365513.2016.1210330","article-title":"microRNAs as cancer biomarkers","volume":"245","author":"Flatmark","year":"2016","journal-title":"Scand. J. Clin. Lab. Investig. Suppl."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.137993_bb0135","article-title":"Laktionov, miRNAs and androgen deprivation therapy for prostate cancer. Biochimica et Biophysica Acta (BBA) - reviews on","volume":"1876","author":"Konoshenko","year":"2021","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.137993_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189067","article-title":"Deregulated miRNAs in enzalutamide resistant prostate cancer: a comprehensive review of key molecular alterations and clinical outcomes","volume":"1879","author":"Tavares","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.137993_bb0145","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/s41388-021-01718-4","article-title":"YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer","volume":"40","author":"Lee","year":"2021","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.137993_bb0150","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/clinchem\/hvaa095","article-title":"Prognostic value of novel liquid biomarkers in patients with metastatic castration-resistant prostate Cancer treated with enzalutamide: a prospective observational study","volume":"66","author":"Benoist","year":"2020","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.137993_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020307","article-title":"3D cell cultures as prospective models to study extracellular vesicles in Cancer","volume":"13","author":"Bordanaba-Florit","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijbiomac.2024.137993_bb0160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/bs.mie.2020.09.005","article-title":"Three-dimensional cell models for extracellular vesicles production, isolation, and characterization","volume":"645","author":"Paniushkina","year":"2020","journal-title":"Methods Enzymol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.137993_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094784","article-title":"Visualizing extracellular vesicles and their function in 3D tumor microenvironment models","volume":"22","author":"Ural","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.137993_bb0170","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/1087057117696795","article-title":"Three-dimensional cell cultures in drug discovery and development","volume":"22","author":"Fang","year":"2017","journal-title":"SLAS Discov"},{"issue":"17","key":"10.1016\/j.ijbiomac.2024.137993_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176225","article-title":"Spheroids as a type of three-dimensional cell cultures-examples of methods of preparation and the Most important application","volume":"21","author":"Bia\u0142kowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"D1","key":"10.1016\/j.ijbiomac.2024.137993_bb0180","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.137993_bb0185","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/1471-2105-12-436","article-title":"clusterMaker: a multi-algorithm clustering plugin for Cytoscape","volume":"12","author":"Morris","year":"2011","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.137993_bb0190","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/nar\/30.7.1575","article-title":"An efficient algorithm for large-scale detection of protein families","volume":"30","author":"Enright","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2024.137993_bb0195","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3389\/fonc.2019.00801","article-title":"Second-generation antiandrogens: from discovery to standard of Care in Castration Resistant Prostate Cancer","volume":"9","author":"Rice","year":"2019","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.137993_bb0200","article-title":"Mechanisms of resistance to second-generation antiandrogen therapy for prostate Cancer: actual knowledge and perspectives","volume":"10","author":"Pinto","year":"2022","journal-title":"Med Sci (Basel)"},{"key":"10.1016\/j.ijbiomac.2024.137993_bb0205","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3389\/fonc.2019.00858","article-title":"Androgen receptor signaling in the development of castration-resistant prostate Cancer","volume":"9","author":"Feng","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.137993_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50220-1","article-title":"Drivers of AR indifferent anti-androgen resistance in prostate cancer cells","volume":"9","author":"Handle","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.137993_bb0215","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000363186","article-title":"PTEN loss-mediated Akt activation increases the properties of cancer stem-like cell populations in prostate cancer","volume":"87","author":"Kim","year":"2014","journal-title":"Oncology"},{"key":"10.1016\/j.ijbiomac.2024.137993_bb0220","doi-asserted-by":"crossref","unstructured":"Teroerde, M., et al., Revisiting the Role of p53 in Prostate Cancer, in Prostate Cancer, S.R.J. Bott and K.L. Ng, Editors. 2021, Exon Publications Copyright: The Authors.: Brisbane (AU).","DOI":"10.36255\/exonpublications.prostatecancer.p53.2021"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.137993_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122535","article-title":"Metabolic reprogramming and predominance of solute carrier genes during acquired enzalutamide resistance in prostate Cancer","volume":"9","author":"Verma","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.137993_bb0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66908-8","article-title":"A synergic approach to enhance long-term culture and manipulation of MiaPaCa-2 pancreatic cancer spheroids","volume":"10","author":"Cavo","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.137993_bb0235","article-title":"E-cadherin, actin, microtubules and FAK dominate different spheroid formation phases and important elements of tissue integrity","volume":"8","author":"Smyrek","year":"2019","journal-title":"Biol Open"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.137993_bb0240","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/ten.teb.2013.0537","article-title":"Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications","volume":"20","author":"Sart","year":"2014","journal-title":"Tissue Eng. Part B Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.137993_bb0245","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/abe6f2","article-title":"Cell spheroids as a versatile research platform: formation mechanisms, high throughput production, characterization and applications","volume":"13","author":"Decarli","year":"2021","journal-title":"Biofabrication"},{"issue":"28","key":"10.1016\/j.ijbiomac.2024.137993_bb0250","doi-asserted-by":"crossref","first-page":"44252","DOI":"10.18632\/oncotarget.10020","article-title":"miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer","volume":"7","author":"Xin","year":"2016","journal-title":"Oncotarget"},{"issue":"46","key":"10.1016\/j.ijbiomac.2024.137993_bb0255","doi-asserted-by":"crossref","first-page":"75585","DOI":"10.18632\/oncotarget.12310","article-title":"C-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer","volume":"7","author":"Maina","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2024.137993_bb0260","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7252013","article-title":"Role of miR-221\/222 in tumor development and the underlying mechanism","volume":"2019","author":"Song","year":"2019","journal-title":"J. Oncol."},{"issue":"32","key":"10.1016\/j.ijbiomac.2024.137993_bb0265","doi-asserted-by":"crossref","first-page":"23716","DOI":"10.1074\/jbc.M701805200","article-title":"miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1*","volume":"282","author":"Galardi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2024.137993_bb0270","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fgene.2012.00286","article-title":"EGFR signaling pathway and related-miRNAs in age-related diseases: the example of miR-221 and miR-222","volume":"3","author":"Teixeira","year":"2012","journal-title":"Front. Genet."},{"key":"10.1016\/j.ijbiomac.2024.137993_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004029","article-title":"The inhibition of the highly expressed Mir-221 and Mir-222 impairs the growth of prostate carcinoma xenografts in mice","volume":"3","author":"Mercatelli","year":"2008","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.137993_bb0280","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/labinvest.2008.94","article-title":"miR-21 plays a pivotal role in gastric cancer pathogenesis and progression","volume":"88","author":"Zhang","year":"2008","journal-title":"Lab. Investig."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.137993_bb0285","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1007\/s13277-014-1918-9","article-title":"Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies","volume":"35","author":"Santos","year":"2014","journal-title":"Tumour Biol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.137993_bb0290","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/pros.22456","article-title":"The altered expression of MiR-221\/\u2212222 and MiR-23b\/\u221227b is associated with the development of human castration resistant prostate cancer","volume":"72","author":"Sun","year":"2012","journal-title":"Prostate"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024088044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024088044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:21:38Z","timestamp":1777483298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024088044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":58,"alternative-id":["S0141813024088044"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.137993","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicles derived-microRNAs predicting enzalutamide-resistance in 3D spheroid prostate Cancer model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.137993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"137993"}}